Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/17300594

Download in:

View as

General Info

PMID
17300594